Ixchel Scientific
Ixchel Scientific is developing diagnostics/prognostics to personalize cancer treatment regimens based on the physiology of an individual tumor.
- Stage Prototype Ready
- Industry Biotechnology
- Location San Jose, CA, US
- Currency USD
- Founded January 2014
- Employees 2
- Website ixchelsci.com
Company Summary
The mission of Ixchel Scientific is to personalize cancer treatment based on the physiology of an individual tumor. Diagnostics/prognostics developed by Ixchel Scientific will allow oncologists to identify therapeutic regimens with low toxicity and high response rates for each patient.
Team
-
Founder & CEOPh.D. in Molecular and Cell Biology with multifaceted expertise in various aspects of cancer biology, including, tumor microenvironment, tumor immunology, drug resistance, diagnostics/prognostics, target discovery, preclinical models and drug screening for efficacy testing.
-
Robert TresslerCSOPh.D. in Biomedical Sciences with expertise in oncology R&D, in vitro and in vivo pharmacology, preclinical development, and FDA regulations with 22 years of experience holding leadership positions in pharmaceutical industry;
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.